[HTML][HTML] Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome

GM Gager, B Biesinger, F Hofer, MP Winter… - Vascular …, 2020 - Elsevier
Abstract Background The interleukin-6 (IL-6) pathway has a crucial role in the pathogenesis
of atherosclerosis, the main cause of cardiovascular diseases. We aimed to characterize the …

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction

A Abbate, FN Salloum, E Vecile, A Das, NN Hoke… - Circulation, 2008 - Am Heart Assoc
Background—Experimental interleukin-1 receptor antagonist gene overexpression has
shown that interleukin-1 receptor antagonist is cardioprotective during global cardiac …

Status of cytokines in ischemia reperfusion induced heart injury

M Zhang, L Chen - Cardiovascular & Haematological Disorders …, 2008 - ingentaconnect.com
Extensive investigations have implicated cytokines such as tumour necrosis factor (TNF)-α
and interleukin (IL)-1, and IL-6 as contributing to the pathology of ischemia-reperfusion (I/R) …

Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis

K Savvatis, I Müller, M Fröhlich, K Pappritz… - Basic research in …, 2014 - Springer
Increased levels of interleukin-6 (IL-6) have been observed in patients with acute
myocarditis and are associated with poor prognosis. This study was designed to examine …

Interleukin-7 and anti–programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression

Y Shindo, J Unsinger, CA Burnham, JM Green… - Shock, 2015 - journals.lww.com
Sepsis remains a major cause of morbidity and mortality in most intensive care units.
Protracted sepsis can evolve into a state of profound immunosuppression characterized by …

IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure

AS Gabriel, A Martinsson, B Wretlind… - European journal of …, 2004 - Elsevier
BACKGROUND: Inflammatory mechanisms in heart disease are of great interest. The
proinflammatory cytokine interleukin (IL) 6 has been linked to increased morbidity in …

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

CA Dinarello, A Simon… - Nature reviews Drug …, 2012 - nature.com
Abstract Interleukin-1 (IL-1) is a highly active pro-inflammatory cytokine that lowers pain
thresholds and damages tissues. Monotherapy blocking IL-1 activity in autoinflammatory …

Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest

M Fries, C Stoppe, D Brücken, R Rossaint… - Journal of Critical Care, 2009 - Elsevier
PURPOSE: Although animal studies document conflicting data on the influence of
hypothermia on cytokine release in various settings, no data exist if hypothermia affects the …

The inflammatory cytokines: new developments in the pathophysiology and treatment of septic shock

MP Glauser - Drugs, 1996 - Springer
Bacterial products [lipopolysaccharide (LPS) with Gram-negative bacteria and toxins,
superantigens or cell wall fragments with Gram-positive bacteria] are the main activators of …

Interleukin 18 in the heart

M Wang, TA Markel, DR Meldrum - Shock, 2008 - journals.lww.com
IL-18, originally termed as interferon γ (IFN-γ) inducing factor, is a proinflammatory cytokine
that belongs to the IL-1 cytokine superfamily. IL-18 plays an important role in immune …